about
Gangliosides for the treatment of diabetic peripheral neuropathyHyperglycemia induces oxidative stress and impairs axonal transport rates in mice.Targeting apoptosis signalling kinase-1 (ASK-1) does not prevent the development of neuropathy in streptozotocin-induced diabetic mice.Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.Overexpression of human HSP27 protects sensory neurons from diabetesCoenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes modelHyperglycemia accelerates apparent diffusion coefficient-defined lesion growth after focal cerebral ischemia in rats with and without features of metabolic syndrome.Dorsal Root Ganglia Sensory Neuronal Cultures: a tool for drug discovery for peripheral neuropathies.Emerging drugs for diabetic neuropathy.Pharmacological treatment of diabetic neuropathic pain.Diabetic peripheral neuropathy: role of reactive oxygen and nitrogen species.Acrolein Scavenger Hydralazine Prevents Streptozotocin-Induced Painful Diabetic Neuropathy and Spinal Neuroinflammation in Rats.The role of G-protein receptor 84 in experimental neuropathic pain.Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
P2860
Q24198249-D3DB9949-E56B-4BE0-AF29-ED875ED37192Q33728395-B132942C-5A78-4267-BC38-A28A56619AABQ35346731-F62E3894-F949-41F6-99D1-BE40F4A90DF4Q35713992-E38CAE4F-5DCE-44F8-ABFE-533210FC1F33Q36084076-4FDA9DEB-A4A6-4AD8-8530-16C7407AC1C6Q36535440-AE9154EA-0AD5-40FF-A301-1D2C783C83DEQ37216100-7E45B85C-0D3D-4F67-A048-C22230056663Q37775522-24EEA5B5-5420-4A56-A871-F91BE775D282Q37783301-E43AE01E-516D-4B5D-99E9-D6039FB0BB09Q37858519-183D30D6-D025-4068-9E01-1B77D65AE982Q38110740-85266AB4-D0DE-485E-9DE1-E9869ACB06CCQ38734248-A95C82DD-E9DA-4993-86BD-1D7C0BD0FADBQ41972808-1DC273C7-A059-46E3-9453-89D8208CFBD8Q41995767-3923B0B4-1529-41DA-9DF3-53BA5810A2E1Q51378923-6894E5B3-5C80-4A69-8885-1C8987054F4B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diabetic neuropathies: components of etiology.
@en
Diabetic neuropathies: components of etiology.
@nl
type
label
Diabetic neuropathies: components of etiology.
@en
Diabetic neuropathies: components of etiology.
@nl
prefLabel
Diabetic neuropathies: components of etiology.
@en
Diabetic neuropathies: components of etiology.
@nl
P2860
P1476
Diabetic neuropathies: components of etiology
@en
P2093
David R Tomlinson
P2860
P304
P356
10.1111/J.1529-8027.2008.00167.X
P577
2008-06-01T00:00:00Z